Aurobindo Pharma Limited (NSE:AUROPHARMA)
India · Delayed Price · Currency is INR 1,193.00
+14.90 (1.26%)
At close: Dec 17, 2025
Aurobindo Pharma Market Cap
Aurobindo Pharma has a market cap or net worth of 692.9 billion as of December 17, 2025. Its market cap has decreased by -5.51% in one year.
Market Cap
692.90B
Enterprise Value
681.84B
Revenue
325.14B
Ranking
n/a
PE Ratio
20.25
Stock Price
1,193.00
Market Cap Chart
Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 692.90B, an increase of 7,115.21%. That is a compound annual growth rate of 19.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 692.90B | -10.60% |
| Dec 31, 2024 | 775.08B | 22.03% |
| Dec 29, 2023 | 635.16B | 147.32% |
| Dec 30, 2022 | 256.82B | -40.31% |
| Dec 31, 2021 | 430.28B | -20.29% |
| Dec 31, 2020 | 539.83B | 101.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.27T |
| Divi's Laboratories | 1.68T |
| Cipla | 1.21T |
| Apollo Hospitals Enterprise | 1.01T |
| Zydus Lifesciences | 920.05B |
| Mankind Pharma | 869.37B |
| Alkem Laboratories | 677.16B |
| Fortis Healthcare | 660.59B |